Welcome!
Sinopharm
Covid-19
Sinopharm says second-generation vaccine approved for trial
The improved vaccine has already been approved by the United Arab Emirates as a booster shot
April 03, 2022
Covid-19
Singapore expands vaccine program to more, to allow import of other vaccines: MTF
Singapore has expanded its vaccination programme to cover more people, including pregnant women and cancer patients,
May 31, 2021
Funds
Vaccine ETFs outperform Nasdaq and S&P500; offer diversified exposure to Covid
A strategic option would be to invest in an exchange traded fund (ETF) with exposure to vaccine-related stocks.
January 15, 2021
Global review
China could well be the winner of the Covid-19 vaccine race
The race is on for the first Covid-19 vaccine, with five Chinese companies among the 10 that are in phase III studies.
October 09, 2020
Covid-19
In coronavirus vaccine race, China inoculates thousands before trials are completed
China is inoculating tens of thousands of its citizens with experimental coronavirus vaccines, despite incomplete trials
September 16, 2020
Covid-19
Chinese companies in the race for a Covid-19 vaccine
During a results briefing by Manulife US REIT’s manager on Aug 3, Jill Smith, CEO of the manager was upbeat about prospects for a vaccine against Covid-19, and hence expects an economic rebound in 2H2020. MUST owns nine properties in the US, of which tw
August 04, 2020